Z79.633
Long term (current) use of mitotic inhibitor
Clinical Classification Guidelines
Inclusion Terms
- Long term (current) use of paclitaxel
- Long term (current) use of plant alkaloids
- Long term (current) use of vinblastine
- Long term (current) use of vincristine
Medical Intelligence & Overview
The ICD-10 code Z79.633 relates to the ongoing use of mitotic inhibitors, a class of chemotherapy drugs used in cancer treatment. These medications interfere with cell division, which helps to slow or stop the growth of cancer cells. Common mitotic inhibitors include paclitaxel, plant alkaloids, vinblastine, and vincristine. Patients on these medications typically require long-term management and monitoring to address potential side effects and ensure treatment effectiveness.
Causes & Symptoms
Clinical Causes: Diagnosis of certain cancers such as ovarian, breast, lung, or lymphatic cancers that require chemotherapy with mitotic inhibitors. Treatment plans involving prolonged or continuous chemotherapy protocols. Use of specific mitotic inhibitors like paclitaxel, vinblastine, or vincristine as part of cancer management.
Key Symptoms: Nausea and vomiting Hair loss Peripheral neuropathy (numbness or tingling in hands and feet) Fatigue and weakness Low blood cell counts leading to increased risk of infection, anemia, or bleeding Muscle weakness or cramps Digestive issues such as constipation or diarrhea Potential liver or kidney function changes General malaise
Diagnostic & Treatment
Diagnosis Path: Monitoring patients on long-term mitotic inhibitors involves regular clinical assessments and laboratory tests. These may include blood counts to check for bone marrow suppression, liver and kidney function tests, and assessments for neurological symptoms. Imaging studies might also be used to evaluate tumor response to therapy.
Treatment Protocols: While this classification focuses on the long-term use of mitotic inhibitors, managing side effects is crucial. Strategies may involve dose adjustments, supportive medications to mitigate side effects like neuropathy or nausea, and regular health check-ups. In some cases, treatment plans are modified to balance cancer control with quality of life. Patients should be under the supervision of specialized healthcare providers who can tailor interventions based on individual response and side effects.
Clinical Advice & FAQs
Billing Guidance
Is Z79.633 a billable ICD-10 code?
Yes, Z79.633 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report Z79.633?
Clinical documentation must specify the nature of Long term (current) use of mitotic inhibitor and any associated comorbidities for accurate reporting.
Cite this Clinical Reference